Product Information

WARFARIN SODIUM 3 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1008 per EA under NDC 51672403007. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Jul 15, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

WARFARIN SODIUM 3 MG TABLET

Warfarin Sodium
$0.1008per EA

Strength

3 mg/1

NDC

51672403007

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

WARFARIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA040301

FDA Approved

7/15/1999

TE Code

AB

On Market Since

7/15/1999

Pharmacological Classes

Vitamin K Antagonist
Vitamin K Inhibitors

Price Statistics

The NADAC for WARFARIN SODIUM 3 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has risen 22.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1008 per EA
All-time high$0.2178 (Nov 12, 2014)
All-time low$0.0779 (Dec 20, 2023)
52-week high$0.1008
52-week low$0.0829
Median price$0.1106
Average price$0.1222
Largest weekly change+82.9% (Sep 3, 2014)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+2.1%

3M

+5.8%

6M

+17.5%

1Y

+4.7%

3Y

-2.1%

5Y

+8.2%

All

+22.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of WARFARIN SODIUM 3 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for WARFARIN SODIUM 3 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.1008 per EA (NDC 51672403007), effective Nov 11, 2026.

How has the price of WARFARIN SODIUM 3 MG TABLET changed over time?

Over the history we have for it, the NADAC for WARFARIN SODIUM 3 MG TABLET has risen 22.6%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for WARFARIN SODIUM 3 MG TABLET?

Since Nov 28, 2013, the NADAC for WARFARIN SODIUM 3 MG TABLET has ranged from a low of $0.0779 (Dec 20, 2023) to a high of $0.2178 (Nov 12, 2014), with a median of $0.1106 per EA.

Are there cheaper alternatives to WARFARIN SODIUM 3 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, JANTOVEN 3 MG TABLET, is $0.0986 per EA — about 2% below WARFARIN SODIUM 3 MG TABLET.

Who manufactures WARFARIN SODIUM 3 MG TABLET?

WARFARIN SODIUM 3 MG TABLET (NDC 51672403007) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.